Luis Almeida, MD, PhD
Luis Almeida, MD, PhD
BlueClinical
Email confirmado em blueclinical.pt - Página inicial
Título
Citado por
Citado por
Ano
Pharmacokinetic and safety profile of trans‐resveratrol in a rising multiple‐dose study in healthy volunteers
L Almeida, M Vaz‐da‐Silva, A Falcão, E Soares, R Costa, AI Loureiro, ...
Molecular nutrition & food research 53 (S1), S7-S15, 2009
3642009
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures: a randomized, double‐blind, placebo‐controlled …
C Elger, P Halász, J Maia, L Almeida, P Soares‐da‐Silva, ...
Epilepsia 50 (3), 454-463, 2009
2492009
Eslicarbazepine acetate (BIA 2-093)
L Almeida, P Soares-da-Silva
Neurotherapeutics 4 (1), 88-96, 2007
1942007
Catechol‐O‐methyltransferase and Its Inhibitors in Parkinson's Disease
MJ Bonifácio, PN Palma, L Almeida, P Soares‐da‐Silva
CNS drug reviews 13 (3), 352-379, 2007
1872007
Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy
E Ben-Menachem, AA Gabbai, A Hufnagel, J Maia, L Almeida, ...
Epilepsy research 89 (2-3), 278-285, 2010
1812010
Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures
A Gil‐Nagel, J Lopes‐Lima, L Almeida, J Maia, P Soares‐da‐Silva, ...
Acta Neurologica Scandinavica 120 (5), 281-287, 2009
1652009
Eslicarbazepine acetate: a double‐blind, add‐on, placebo‐controlled exploratory trial in adult patients with partial‐onset seizures
C Elger, M Bialer, JA Cramer, J Maia, L Almeida, P Soares‐da‐Silva
Epilepsia 48 (3), 497-504, 2007
1392007
Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects
L Almeida, PS da Silva, A Falcão, J Maia, D Mazur, M Gellert
1102005
Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment
L Almeida, JH Potgieter, J Maia, MA Potgieter, F Mota, P Soares-da-Silva
European journal of clinical pharmacology 64 (3), 267-273, 2008
1042008
Long‐term efficacy and safety of eslicarbazepine acetate: Results of a 1‐year open‐label extension study in partial‐onset seizures in adults with epilepsy
P Halász, JA Cramer, D Hodoba, A Członkowska, A Guekht, J Maia, ...
Epilepsia 51 (10), 1963-1969, 2010
972010
Pharmacokinetics of Trans‐resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects
T Nunes, L Almeida, JF Rocha, A Falcão, C Fernandes‐Lopes, ...
The Journal of Clinical Pharmacology 49 (12), 1477-1482, 2009
942009
Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate
J Maia, L Almeida, A Falcao, E Soares, F Mota, MA Potgieter, JH Potgieter, ...
International journal of clinical pharmacology and therapeutics 46 (3), 119, 2008
922008
Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate
J Maia, L Almeida, A Falcao, E Soares, F Mota, MA Potgieter, JH Potgieter, ...
International journal of clinical pharmacology and therapeutics 46 (3), 119, 2008
922008
Effect of food on the pharmacokinetic profile of trans-resveratrol
M Vaz-da-Silva, AI Loureiro, A Falcao, T Nunes, JF Rocha, ...
Int J Clin Pharmacol Ther 46 (11), 564-70, 2008
862008
Efficacy and safety of eslicarbazepine acetate as add‐on treatment in patients with focal‐onset seizures: integrated analysis of pooled data from double‐blind phase III …
A Gil‐Nagel, C Elger, E Ben‐Menachem, P Halász, J Lopes‐Lima, ...
Epilepsia 54 (1), 98-107, 2013
782013
Why healthy subjects volunteer for phase I studies and how they perceive their participation?
L Almeida, B Azevedo, T Nunes, M Vaz-da-Silva, P Soares-da-Silva
European journal of clinical pharmacology 63 (11), 1085-1094, 2007
772007
Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open …
A Hufnagel, E Ben-Menachem, AA Gabbai, A Falcão, L Almeida, ...
Epilepsy research 103 (2-3), 262-269, 2013
712013
Safety, tolerability, and pharmacokinetic profile of BIA 2‐093, a novel putative antiepileptic, in a rising multiple‐dose study in young healthy humans
L Almeida, P Soares‐da‐Silva
The Journal of Clinical Pharmacology 44 (8), 906-918, 2004
672004
Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsy
L Almeida, I Minciu, T Nunes, N Butoianu, A Falcão, SA Magureanu, ...
The Journal of Clinical Pharmacology 48 (8), 966-977, 2008
642008
Steady‐state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers
T Nunes, JF Rocha, A Falcão, L Almeida, P Soares‐da‐Silva
Epilepsia 54 (1), 108-116, 2013
622013
O sistema não pode efectuar a operação agora. Tente novamente mais tarde.
Artigos 1–20